Revenues in first quarter of 2025 were $8.9 million, up 18% over revenue of the same period last year. Appointed a new Chief Commercial Officer, Mr. Michel Roy, a leader in the pharma industry.

MONTREAL, QC / ACCESSWIRE / December 3, 2020 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral ...

Revenue in 2024 grew to $34.9 million, a 45% increase over 2023 revenue of $24.1 million. Completed an underwritten public offering of approximately $10 million in gross proceeds for expansion of ...

The generic drug market has been growing since 1984 when the Hatch-Waxman Act encouraged manufacturing generics and developed a framework to regulate them. Apart from name difference, generic drugs ...

One of today’s big movers is Sunshine Biopharma (NASDAQ:SBFM). Any stock that appreciates 160%-plus on a given day is worth checking out. Today, investors in SBFM stock are seeing such a move, on ...

Sunshine Biopharma (NASDAQ:SBFM) stock is shining brighter on Tuesday after revealing the effects its mRNA molecules have against cancer. Source: Shutterstock Two of the mRNA molecules developed by ...

FORT LAUDERDALE, FL / ACCESS Newswire / March 10, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic ...

With two groundbreaking drugs for COVID-19 and multidrug-resistant cancer in the pipeline and their first science-backed nutritional supplement on the market, Sunshine Biopharma is poised to change ...

What Happened: Sunshine Biopharma paid C$30 million (approximately $21.9 million) in cash, shares, and an earn-out amount. As of June, Sunshine held around $42 million in cash balance. The addition of ...